Search results

  1. Further research is recommended to assess the diagnostic yield of the BioMonitor 2‑AF and Confirm Rx (or later devices) for atrial fibrillation when used in people who have had a cryptogenic stroke. The committee noted that existing ongoing research may provide further data for these devices (see  section 3.51   and  section 4.19 ).

    Recommendation ID DG41/1 Question Further research is recommended to assess the diagnostic yield of the BioMonitor 2‑AF and Confirm Rx

  2. NICE encourages further research into implanted vagus nerve stimulation for treatment-resistant depression, in the form of randomised controlled trials with a placebo or sham stimulation arm. Studies should report details of patient selection. Outcomes should include validated depression rating scales, patient-reported quality of life, time to onset of effect and duration of effect, and any changes in concurrent treatments.

    Recommendation ID IPG679/1 Question NICE encourages further research into implanted vagus nerve stimulation for treatment-resistant depression

  3. SEM Scanner 200, with visual skin assessment, shows promise for preventing pressure ulcers. However, there is not enough good-quality evidence to support the case for routine adoption in the NHS. A randomised controlled trial is recommended to address uncertainties about the clinical benefits of using the scanner compared with standard risk assessment. This should assess: using the scanner plus visual skin assessment compared with visual skin assessment alone for identifying pressure ulcer risk whether changes in clinical decision making from using the scanner reduce pressure ulcer incidence the clinical benefits and resource impact of using the scanner in different care settings the clinical benefits for different skin tones how well the scanner works across populations with a range of comorbidities patient-related outcome measures.

    Recommendation ID MTG51/1 Question SEM Scanner 200, with visual skin assessment, shows promise for preventing pressure ulcers. However

  4. Stroke

    Everything NICE has said on preventing, diagnosing and managing stroke and transient ischaemic attack (TIA) in people over 16 in an interactive flowchart

  5. Heavy menstrual bleeding (QS47)

    This quality standard covers assessing and managing heavy menstrual bleeding (menorrhagia), including suspected or confirmed fibroids and adenomyosis. It describes high-quality care in priority areas for improvement.

  6. Heavy menstrual bleeding

    Everything NICE has said on assessing and managing heavy menstrual bleeding in an interactive flowchart

  7. Pressure ulcers

    Everything NICE has said on preventing and managing pressure ulcers in all age groups in primary care and community settings in an interactive flowchart

  8. Advanced breast cancer

    Everything NICE has said on diagnosing and treating advanced breast cancer in an interactive flowchart

  9. Oral and dental health

    Everything NICE has said on oral and dental health in an interactive flowchart

  10. Renal cancer

    Everything NICE has said on renal (kidney) cancer in an interactive flowchart

  11. Constipation

    Everything NICE has said on constipation in an interactive flowchart

  12. Contraception

    Everything NICE has said on contraceptive services, long-acting reversible contraception and sterilisation in an interactive flowchart

  13. Non-Hodgkin's lymphoma

    Everything NICE has said on diagnosing and managing non-Hodgkin's lymphoma in adults and young people 16 years and older in an interactive flowchart

  14. Psychosis and schizophrenia

    Everything NICE has said on recognising and managing psychosis and schizophrenia in children, young people and adults in an interactive flowchart

  15. Skin conditions

    Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart

  16. Epilepsy

    Everything NICE has said on diagnosing and managing the epilepsies in adults and children in primary and secondary care in an interactive flowchart

  17. Suspected cancer recognition and referral

    Everything NICE has said on suspected cancer, recognition and selection for referral or investigation in primary care in an interactive flowchart

  18. Neuropathic pain

    Everything NICE has said on pharmacological management of neuropathic pain in adults in non-specialist settings in an interactive flowchart

  19. Hypertension

    Everything NICE has said on managing hypertension in adults in an interactive flowchart

  20. Hip fracture

    Everything NICE has said on managing hip fracture in adults in an interactive flowchart

  21. Depression

    Everything NICE has said on identifying, treating and managing depression in children, young people and adults in an interactive flowchart

  22. Urinary tract infections

    Everything NICE has said on diagnosing, treating and managing urinary tract infections including lower (cystitis), upper (acute pyelonephritis) and recurrent UTIs in people with or without a catheter in an interactive flowchart